FDA Adverse Event Injury Summary report: N

HAKIM PROGRAMMABLE MICRO VALVE

MDR report key: 6789332 · Received August 11, 2017

Report

Report Number
1226348-2017-10575
Event Type
Injury
Date Received
August 11, 2017
Date of Event
June 7, 2017
Manufacturer
CODMAN & SHURTLEFF, INC. / MEDOS S.A.
Product Code
JXG
PMA / PMN Number
K980778
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). UPON COMPLETION OF THE INVESTIGATION A FOLLOW UP REPORT WILL BE FILED.

Additional Manufacturer Narrative · 1

(B)(4). UPON COMPLETION OF THE INVESTIGATION IT WAS NOTED THAT THE IMAGES WERE TAKEN OF THE ¿AS RECEIVED¿ VALVE. THE POSITION OF THE CAM WHEN VALVE WAS RECEIVED WAS 160 MMH2O. THE VALVE WAS VISUALLY INSPECTED: A CLEAR LIQUID WAS NOTED INSIDE THE VALVE. THE VALVE WAS HYDRATED. THE VALVE WAS TESTED FOR PROGRAMMING WITH PROGRAMMER 82-3126 WITH SERIAL (B)(4), THE VALVE PASSED THE TEST. THE VALVE WAS FLUSHED, THE VALVE PASSED THE TEST NO OCCLUSION WAS NOTED. THE VALVE WAS LEAK TESTED, ONLY LEAKED FROM THE NEEDLE HOLES OVER THE NEEDLE GUARD. THE VALVE WAS REFLUX TESTED. THE VALVE PASSED THE TEST. THE VALVE WAS DRIED. THE VALVE WAS THEN PRESSURE TESTED, THE VALVE PASSED THE TEST. REVIEW OF THE HISTORY DEVICE RECORDS CONFIRMED THE VALVE PRODUCT CODE 82-3112, WITH LOT CVFBY4 CONFORMED TO THE SPECIFICATIONS WHEN RELEASED TO STOCK IN 26TH MAY 2016. NO ROOT CAUSE COULD BE DETERMINED, AS THE PROBLEM REPORTED BY THE CUSTOMER COULD NOT BE DUPLICATED. BASED ON THE RESULTS OF THIS INVESTIGATION NO FURTHER ACTION IS REQUIRED. TRENDS WILL BE MONITORED FOR THIS AND SIMILAR COMPLAINTS. AT THE PRESENT TIME THIS COMPLAINT IS CLOSED.

Description of Event or Problem · 1

BLOCKED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
569680 HAKIM PROGRAMMABLE MICRO VALVE SHUNT, CENTRAL NERVOUS SYSTEM & COMPS JXG CODMAN & SHURTLEFF, INC. / MEDOS S.A. CVFBY4

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention